You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Israel

Feb 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Slower growth for consumer health in 2011

During 2011, the consumer health market showed slower growth than was seen over the review period. The slower growth was due to rising regulatory involvement within the consumer health category, which led many players to invest in products outside of the category, such as medical devices, cosmetics and vitamins and dietary supplements (VDS). As a result, the VDS category attracted new players which in turn increased competition, drove prices down and thus also slowed growth of the overall category.

The government becomes more proactive in public health issues

In 2011, the Israeli government took a more proactive stance against addiction related issues. Within consumer health care this concern manifested in regulations on products that, when abused, can damage the health. For example, oral decongestants became regulated in an effort to alert the public to the damages of long-term use of these products. Laxatives were switched to Rx status in response to young Israeli women abusing these products for the purpose of losing weight. Another regulatory action by the government was an attempt to regulate the prices of all consumer health products.

New key product categories increase competition and push prices down

As VDS products are relatively easier than consumer health to produce and to import, and their prices are not regulated, the VDS category in Israel is more attractive to companies in which to launch new products. In 2011 there was increased competition within categories such as omega 3-6-9 and glucosamine. New players, previously specialising in consumer health, entered those categories in search of larger profit margins. The growing competition in VDS caused a decrease in average unit price and a slowing of growth of the whole category.

The popularity of VDS products boosts sales of healthfood shops

The strong growth of VDS caused healthfood shops to continue gaining shares in 2011. Healthfood shops tend to have professional staff, who offer personal consultation, an important factor for Israeli consumers as they like to consult perceived professionals. Healthfood shops are also gaining popularity as the leading chained retailers are competing to acquire them in order to incorporate health and organic activity within their mainstream formats.

Slower growth forecast for the consumer health market

Consumer health sales will continue to increase over the forecast period as self-medication is high in Israel and consumers are happy to resort to consumer health remedies for mild ailments such as flu, headaches or indigestion before visiting a doctor. A growing proportion of consumers will prefer to treat such ailments through VDS alternatives. However, both consumer health and VDS categories are expected to witness slower growth as a result of growing regulatory involvement in the consumer health category, which will cause even more players to seek opportunities and higher profit margins in unregulated products, such as medical devices, cosmetics and VDS. The VDS category, in turn, is expected to continue seeing growing competition within the larger categories such as omega 3-6-9 and glucosamine, and new players in categories such as probiotics.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Israel with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Israel, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Israel for free:

The Consumer Health in Israel market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Israel?
  • What are the major brands in Israel?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Israel - Industry Overview

EXECUTIVE SUMMARY

Slower growth for consumer health in 2011

The government becomes more proactive in public health issues

New key product categories increase competition and push prices down

The popularity of VDS products boosts sales of healthfood shops

Slower growth forecast for the consumer health market

KEY TRENDS AND DEVELOPMENTS

The government becomes more proactive in public health issues

New type of product enters the VDS market

Key new product categories increase competition, pushing prices down

Market segmentation leads to more female-specific products in VDS

A period of social unrest in 2011 leads to greater consumer price sensitivity

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Israel - Company Profiles

Chemipal Ltd in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Chemipal Ltd: Competitive Position 2011

Dexxon Ltd in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Dexxon Ltd: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 9 Dexxon Ltd: Competitive Position 2011

Rekah Pharmaceutical Products Ltd in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Rekah Pharmaceutical Products Ltd: Competitive Position 2011
  • Summary 13 Vitamed Pharmaceutical Industries Ltd: Competitive Position 2011

Ta'am Teva-Altman General Partnership in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Ta’am Teva-Altman General Partnership: Competitive Position 2011

Teva Pharmaceutical Industries Ltd in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 19 Teva Pharmaceutical Industries Ltd: Competitive Position 2011

Adult Mouth Care in Israel - Category Analysis

HEADLINES

TRENDS

  • In 2011, companies preferred to invest in medical devices, VDS or cosmetics categories, in which prices are not regulated enabling higher profit margins. As a mature, small category with limited innovation possibilities, adult mouth care was one of the consumer health categories particularly vulnerable to this general trend.

SWITCHES

COMPETITIVE LANDSCAPE

  • Taro Pharmaceutical Industries continued to lead sales in 2011, with a value share of 26%. The company’s leading brand is Tarodent, with 22% of sales, supported by Anadent, with 4%. Taro managed to improve its competitive positioning during 2010 with an increase in share of half a percentage point.

PROSPECTS

  • In response to the growing demand for alternative products in VDS and homeopathic categories, and as only limited innovation is possible within the category itself, leading manufacturers are expected to focus on launching new delivery systems with the same ingredients. Companies are also likely to develop new variants of their brands with herbal ingredients and to focus their marketing efforts around these.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Israel - Category Analysis

HEADLINES

TRENDS

  • The analgesics category proved to be particularly durable in 2011, as it was the subject of extensive negative media attention. There were growing concerns in professional and semi-professional publications about the dangers of analgesics and ibuprofen-based products in particular. Mainstream news outlets carried this growing concern, influenced in part by two hospitalisations after self-medication. In February 2011, a man collapsed after taking a single Optalgin pill, and a month later, a 27-year old woman suffered liver failure and collapsed into comma after consuming a few capsules of Nurofen. The second case in particular received wide media coverage with daily updates on her condition. Two additional stories of sabotage of Nurofen in the UK and a recall of analgesics in the US were also reported by the Israeli media as a part of the “drama” surrounding analgesics at that time.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Pharmaceutical Industries continued to lead analgesics sales in Israel in 2011, with a 41% value share. This was mainly thanks to the continuing strong performance of its Acamol and Optalgin brands.

PROSPECTS

  • The analgesics category is expected to grow by a CAGR of 4% in constant value terms over the forecast period. The desire for more effective analgesics will encourage some consumers to consult doctors, which in turn will lead to purchases of prescription products. Growth will also continue to be hampered by the fact that pricing regulations will limit players’ ability to raise their unit prices.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Israel - Category Analysis

HEADLINES

TRENDS

  • Within the wider calming and sleeping products landscape, including herbal products and VDS, many Israelis prefer all-natural supplements or Rx drugs. Nevertheless, Rx is gaining in popularity, as it is relatively easy to attain subsidised Rx through HMO, and there is no need to go to a specialist, and these medicines can be obtained through family doctors at a discount. Furthermore, as the country is in continuing conflict, there are fewer stigmas in using calming products and family doctors are increasingly willing to prescribe prescription drugs.

SWITCHES

COMPETITIVE LANDSCAPE

  • Promedico is the most popular player in the market thanks to its Nerven Dragees brand, and accounted for a 39% value share. Careline (Pharmagis) suffered the most significant drop in share of six percentage points to reach 20% with its Sleep Aid brand. Nevertheless, both brands remained in the lead thanks to their strong reputations and recommendations by medical professionals at points of sale.

PROSPECTS

  • During the forecast period calming and sleeping products is expected to register a 20% CAGR in constant terms, which will be much higher than the 7% CAGR in constant terms recorded over the review period. Israelis are likely to continue preferring either prescription or herbal products, though this polarisation is expected to take its toll on consumer health calming and sleeping products in the long-term.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Israel - Category Analysis

HEADLINES

TRENDS

  • The Israeli Ministry of Health continued the 2010 regulation on oral decongestants and products that contain codeine. While the 2010 regulations focused on sales of paediatric oral cough and cold remedies, from 2011 adults can buy such products when purchased over the counter from pharmacists and with the presentation of an ID. These measures were extremely effective in alerting consumers to the dangers of oral decongestants. As a result, more adults turned to natural dietary supplements, such as Echinacea for the treatment of mild cold symptoms. This had an impact on consumer health sales, with oral decongestants showing a decline of 20% in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • The cough, cold and allergy (hay fever) remedies category continued to be led by Teva Pharmaceutical Industries in 2011, with a 25% value share. The company enjoys a good reputation in the Israeli market. It owns a wide range of brands, including Acamol and Coldex, which are the leading brands in the largest category of combination products with 35% and 15% value shares, respectively. Teva also owns Alrin, the second strongest brand in nasal decongestants, with a 13% value share.

PROSPECTS

  • The cough, cold and allergy (hay fever) remedies category is expected to grow at a CAGR of 4% over the forecast period. However, as authorities and consumers become increasingly aware of the issue of misuse of decongestants, more restrictions are expected to be implemented. Growth will also continue to be hampered by pricing regulations limiting players’ ability to raise their unit prices.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Israel - Category Analysis

HEADLINES

TRENDS

  • During 2011 awareness about the misuse of digestive remedies among consumers rose. The main concern was for the youth and weaker populations who are less aware of this issue. The Israeli government became more proactive and regulated a few OTC drugs back to Rx and re-considered the active ingredients for more strict regulations. Israelis tend to value the opinion of medical professionals and therefore when warnings are issued over certain products, sales of such products have a tendency to decline, at least for a time.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Pharmaceutical Industries remained the category leader in 2011, with a 28% value share. In spite of the value decrease of the laxatives category, the company continued to lead with its Laxadin and Agiocur brands.

PROSPECTS

  • As a result of the new regulations, laxatives is expected to witness even slower growth over the forecast period declining by a CAGR of 5%. Stronger regulations within the general digestive products is expected, with VDS products switched to OTC and OTC to Rx.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Israel - Category Analysis

HEADLINES

TRENDS

  • The category growth continued to be fuelled by the increasing attention to aesthetics, with most products focusing on the cosmetics aspect of ear treatment. In 2011 new products for the softening of ear wax were launched as well as for cleaning the ear after swimming. These developments pinpoint the direction in which ear care products are heading - more specific treatments that deal with lighter issues around anaesthetics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Vitamed is the strongest company in the category with a 46% value share in 2011. The company operates one of the strongest brand names, Anaesthetic, in ear care. This brand benefits from a strong reputation due to recommendations by medical professionals.

PROSPECTS

  • Ear care is not a very dynamic environment in terms of innovations and new products, and this is expected to continue into the forecast period. The category will continue to be driven from growing consumer awareness of ear treatments on one hand and consumer willingness to try new alternatives on the other.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Israel - Category Analysis

HEADLINES

TRENDS

  • In December 2010, a new brand entered the Israeli market, ending the 10-year monopoly of the Postinor brand marketed by Trima. The new brand, NorLevo, was launched by CTS and stimulated the competitive environment and positive growth in 2011.This launch was among the most significant events during the year in the entire consumer health market, as emergency contraception is a very sensitive type of product, and had been dominated by a single brand. This brand, Postinor became a generic brand name for emergency contraception products, and enjoys a very positive reputation.

COMPETITIVE LANDSCAPE

  • Despite losing its monopoly, Trima continued to control 87% of the market thanks to its Postinor brand. Another contributing factor is the similar price between the two brands – new customers have little incentive to try the new product and those who have used Postinor tend to display high brand loyalty.

SWITCHES

PROSPECTS

  • The entrance of a second player, CTS, is expected to continue having a substantial impact on the competitive environment within emergency contraception. As the competition grows within the category, the average unit price of emergency contraception products is expected to decrease slightly, as competition is expected to drive prices down. CTS will not be satisfied by its relatively poor results, and will continue to be creative and aggressive with marketing activities.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2006-2011
  • Table 54 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 55 Emergency Contraception Company Shares by Value 2007-2011
  • Table 56 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 57 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Israel - Category Analysis

HEADLINES

TRENDS

  • In recent years, Israelis have become increasingly concerned about their appearance. Around 25,000 laser eye surgeries are performed each year, with 220,000 Israelis already having undergone the procedure. This creates a constant growing demand for standard eye care that treats dry eyes after the procedure.

SWITCHES

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2006-2011
  • Table 60 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 61 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 62 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 63 Eye Care Company Shares by Value 2007-2011
  • Table 64 Eye Care Brand Shares by Value 2008-2011
  • Table 65 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Israel - Category Analysis

HEADLINES

TRENDS

  • Overall, herbal/traditional products continued to benefit from an increasing positive reputation, with more consumers willing to try them. The image of these products is of being natural and harmless. The category witnessed 6% growth in 2011 due to the continuing trend towards healthier lifestyles in Israel. The use of herbal products is evident in most consumer categories, as this trend affects most demographics. However, the group that uses herbal/traditional products the most are parents of young children as they perceive these products as less damaging to their children. For that reason the fastest growing category was herbal paediatric dietary supplements in 2011.

COMPETITIVE LANDSCAPE

  • Chocotrade continues to lead sales of herbal/traditional products in Israel, with a value share of 16% in 2011. The company owns the strongest brand in medicated confectionery, Ricola. Ricola dominates its category with an 88% value share. However, Chocotrade continues losing a competitive share of the market mainly due to stronger competition from new VDS alternatives.

PROSPECTS

  • Herbal/traditional products is expected to register a 5% CAGR over the forecast period in constant terms. The performance will continue to be positive as a result of many consumers opting for herbal products. However, the growth is expected to decelerate, due to slowdown in the VDS category as a result of intensifying competition.

CATEGORY DATA

  • Table 67 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 68 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 69 Herbal/Traditional Products Company Shares 2007-2011
  • Table 70 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 71 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 72 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Israel - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care exemplifies the recent slowdown of growth in consumer health due to strict regulations. Companies in Israel have recently realised the strong potential among the more profitable medical devices within medicated skin care products. There are many different products within medicated skin care. Lice treatment, for example, is highly influenced by sales of medical devices.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis NCH ranked first in medicated skin care in 2011 with a value share of 21%. Its leading brand, Procto Glyvenol held an 83% share of haemorrhoid treatments.

PROSPECTS

  • The competition seen in the last two years of the review period is expected to intensify. Medicated skin care is expected to continue to witness intense competition from non-consumer health alternatives, such as medical devices and cosmetics during the forecast period.

CATEGORY DATA

  • Table 73 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 74 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 75 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 76 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 77 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Israel - Category Analysis

HEADLINES

TRENDS

  • In 2011 the Israeli government took a more proactive stance against addiction in a number of categories. Smoking continues to be popular and around 10,000 Israelis die from smoking each year, according to the pharmacists association of Israel. This is more than the combined number of deaths as a result of accidents, acts of terror and HIV. The number of government subsidised options for quitting increased in 2011. The most popular one is a quitting package, that includes Rx drugs, a support group and continuity treatment with consumer health drugs subsidised by the HMO. There is a growing awareness that it is better to stop smoking with the support of a group rather than individually, with most consumers opting for the quitting package in order to benefit from the personal encouragement provided by other people.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis NCH leads sales of NRT smoking cessation aids with a 34% value share via its Nicotinell brand. However, the market is fairly evenly divided between Nicorette from Johnson & Johnson following with 33% and Niquitin by GlaxoSmithKline with 31%. The three brands are equally recommended and usually the company to offer the largest discount has the advantage.

PROSPECTS

  • The quitting packages are expected to continue posing a threat to sales of NRT smoking cessation aids. Consumers are likely to choose the package as it provides continued and personal support unlike consumer health variants. The quitting packages also help those trying to quit to feel part of a community and that sharing their struggles has been proven to be an influential motivator. In addition, Champix is gaining a strong reputation in Israel and its addition to the health basket is likely to pose a stronger threat in the future. For these reasons, NRT smoking cessation aids is predicted to grow by a 4% CAGR over the forecast period, lower than the 5% CAGR recorded over the review period in constant terms.

CATEGORY INDICATORS

  • Table 80 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 81 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 82 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 83 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 84 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 85 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Israel - Category Analysis

HEADLINES

TRENDS

  • Israeli consumers value the opinion of professionals when it comes to their health. For sports nutrition products, the trainer in the gym is slowly gaining such status. Besides the perceived authority of the trainer, when he/she is also seen using products that are then recommended, the products are perceived to have reliability. Companies are also starting to realise the potential of selling through gyms and as a result, the gym is becoming a more important distribution channel. Almost all gyms are affiliated with one company or another, often with selling points on the premises. In most gyms, there is also a foodservice outlet where RTD recommended products can be tasted, usually protein powders.

COMPETITIVE LANDSCAPE

  • Tevacom leads in sports nutrition holding a 22% value share in 2011. However, the market is extremely segmented with over half belonging to many small import companies.

PROSPECTS

  • Sports nutrition is expected to grow by a CAGR of 1% in constant terms over the forecast period. The strong performance will be due to growing awareness of organised sport in Israel. Furthermore, the popularity of supplements in general is expected to develop.

CATEGORY DATA

  • Table 88 Sales of Sports Nutrition: Value 2006-2011
  • Table 89 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 90 Sports Nutrition Company Shares 2007-2011
  • Table 91 Sports Nutrition Brand Shares 2008-2011
  • Table 92 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Israel - Category Analysis

HEADLINES

TRENDS

  • Strict price, marketing and advertising regulations of the consumer health market drove existing companies in the category and new ones to enter the vitamins and dietary supplements category in the hope of benefiting from this category’s rapid growth. Furthermore, the registration process is cheaper and faster and while vitamins and dietary supplements are forbidden to specify the medical condition for which they treat, there are many ways to get around this restriction. The entrance of companies that specialise in consumer health or cosmetics, such as Dr Fischer, are changing the competitive environment and making it tighter. This in turn had a wide impact on the VDS category in terms of growth and marketing strategies in 2011.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Ta’am Teva-Altman General Partnership was the leading player within vitamins and dietary supplements in 2011, with a 27% value share due to its dominance in the largest elements within the category. Its brands hold 39% of paediatric vitamins and dietary supplements, 37% of omega 3-6-9 and 32% of single vitamins.

PROSPECTS

  • Vitamins and dietary supplements is expected to grow by a 5% CAGR in constant terms over the forecast period. This will be the same for the review period CAGR of 5% in constant terms, despite a rise in competition and decrease in prices in most categories.

CATEGORY DATA

  • Summary 20 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 96 Dietary Supplements by Positioning 2006-2011
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 99 Vitamins Brand Shares by Value 2008-2011
  • Table 100 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Israel - Category Analysis

HEADLINES

TRENDS

  • The most evident trend of 2011 is products that target a new niche audience such as women who recently gave birth. This trend goes beyond the usual segmentation of the market and marketing gender or age specific products, in that it appeals to the somewhat emotional state of new mothers and applies to all women, no matter their age. The desire to get back to her pre-pregnancy figure is also strong among many new mothers as well as women who have had many children. Most new products also blur the line with VDS products, promising not only to help in weight loss, but also to do this naturally making it suitable for women who breastfeed.

COMPETITIVE LANDSCAPE

  • Super-Pharm (Israel) retained its outright lead in the category in 2011 with a 26% value share, thanks to its ownership of the strongest private label. Its Diet for Life private label has become household name and is not only known for its economy variants. Its Diet for Life brand was re-launched in 2011 with improved formula and new packaging. It also enjoys considerable shelf space within Super-Pharm and a good reputation. Diet for Life leads sales within weight loss supplements with a 26% brand value share.

PROSPECTS

  • Over the forecast period, the category is expected to decline by a CAGR of 3% compared to a negative CAGR of 5% over the review period. However, weight loss supplements is expected to show increasingly positive growth, compensating for lack of interest in other categories.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2006-2011
  • Table 104 Sales of Weight Management: % Value Growth 2006-2011
  • Table 105 Weight Management Company Shares 2007-2011
  • Table 106 Weight Management Brand Shares 2008-2011
  • Table 107 Forecast Sales of Weight Management: Value 2011-2016
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Israel - Category Analysis

HEADLINES

TRENDS

  • There was growing unrest in 2011 because of the high cost of living in Israel, influencing consumers to be a little more conservative when managing their budgets. Within wound care, consumers returned to purchasing private label. Private label wound treatment sales traditionally show growth when consumers feel less confident in their economic situation. The growth is usually at the expense of the leading brands, Band-Aid and Nexcare.

COMPETITIVE LANDSCAPE

  • Chemipal leads wound care with a 28% share of value sales in 2011. Its Nexcare brand has a strong brand presence within sticking plasters, with a 22% value share, and gauze, tape and other wound care, with a 36% value share. The second most dynamic company in wound care was Haim Danon, which holds a 25% value share of gauze, tape and other wound care with its Eged Gaza Mitmateach brand.

PROSPECTS

  • Wound care is expected to witness a positive CAGR of 3% in constant terms over the forecast period. With the rising share of private label, unit prices are likely to suffer thus constraining further value growth of wound treatment products.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2006-2011
  • Table 110 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 111 Wound Care Company Shares by Value 2007-2011
  • Table 112 Wound Care Brand Shares by Value 2008-2011
  • Table 113 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Black Cohosh
            • Cranberry
            • Mushroom Extract
            • Papaya
            • Pomegranate
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Propolis
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!